Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

“…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

“…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”

Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)^b'*'. by Muxi Chen (9294270)

(A-C) Force versus drill depth and torque versus drill depth. by Marsel Ganeyev (21453399)

Manhattan plot for genome-wide association study (GWAS) in a European population with depression. by Xiaomei He (795333)

“…<p>A: The x-axis represents the chromosomal position, and the y-axis represents the significance on a –log10 scale. …”

The influence of H₂O₂ on <i>P</i>. <i>berghei</i> infection in <i>A</i>. <i>stephensi</i>. by Li Gao (131516)

The levels of NF-κB related inflammatory factors, TERT expression and telomerase relative length are significantly increased in the ovarian tissue of PCOS rats. by Haoxuan Xue (19949764)

Graph of surface roughness values of specimens after testing with different particle sizes at a concentration of 0.4 mg/mL (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

RV PV loop eccentricity during CPR. by Woo Jin Jung (3279570)

Basic physical parameters of shield residue. by Shoujie Wang (18326754)

“…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”

Primary composition of experimental materials. by Shoujie Wang (18326754)

“…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”

Compaction test results. by Shoujie Wang (18326754)

“…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”

Experimental mix proportions. by Shoujie Wang (18326754)

“…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …”